Antibiotic TDM: Alsachim's internal standards in the spotlight
Published : 09/07/2020 - Categories : News
Alsachim is proud to have contributed to Prof L.A. Decosterd's research work, Laboratory of Clinical Pharmacology, University Hospital of Lausanne (Switzerland) and his team, by providing stable isotope-labeled internal standards necessary for the development of the method :
Validation and clinical application of an HPLC-MS/MS multiplex assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections.
These internal standards have been synthesized by Alsachim's R&D team to meet the specific needs of this work: Cefepime-13CD3, Ceftazidime-D6, Ceftriaxone-13CD3, Ertapenem-D4, Flucloxacillin-13C415N, Imipenem-D4, Piperacillin-D5.
Through the synthesis of labeled compounds and the development of controls, calibrants, internal standards and ready-to-use diagnostic kits, Alsachim is a partner of choice for your research in Therapeutic Drug Monitoring.
Share this news
News categories
News archives
- 2024 (1)
- 2023 (4)
- 2022 (4)
- 2021 (4)
- 2020 (11)
- 2019 (4)
- 2018 (1)
- 2017 (1)